DEJIMA Infectious Disease Research Alliance (DIDA)
Nagasaki University
EN
JP
Home
About DIDA
From the President of Nagasaki University
From the Director of DIDA
Organization
Tokyo Office
Vaccine Research and Development Center
Home
About DIDA
From the President of Nagasaki University
From the Director of DIDA
Organization
Tokyo Office
Vaccine Research and Development Center
EN
JP
Nagasaki Dejima Illustration, drawn by KAWAHARA Keiga:owned by the Nagasaki University Library
Scroll
Topics
2025.12.8
Vaccine Research and Development Center
Research Highlights
Highly Pathogenic Virus Therapeutics Development Team:Announcement on「Crimean-Congo hemorrhagic fever virus NSm protein inhibits the type I interferon signaling by binding to STAT2」 2025/11/4
2025.12.1
Vaccine Research and Development Center
Research Highlights
Infectious Disease Medical Epidemiology Team:Announcement on「Infectious Disease Medical Epidemiology Team:Announcement on Continuing to be cautious: Japanese contact patterns during the COVID-19 pandemic and their association with public health recommendations」 2025/9/24
2025.12.1
Vaccine Research and Development Center
Research Highlights
Infectious Disease Medical Epidemiology Team:Announcement on「Stakeholder meeting report: Chikungunya virus – recent outbreaks, vaccine development and the way forward」 2025/9/19
2025.12.1
Vaccine Research and Development Center
Research Highlights
Infectious Disease Medical Epidemiology Team:Announcement on「Disentangling temporal trends of clade Ib monkeypox virus transmission in Burundi」 2025/9/10
2025.12.1
Vaccine Research and Development Center
Research Highlights
Infectious Disease Medical Epidemiology Team:Announcement on 「Vaccination strategies to achieve outbreak control for MPXV Clade I with a one-time mass campaign in sub-Saharan Africa: A scenario-based modelling study」 2025/9/5
View all
2025.4.7
News
Professor Koichi Morita Receives the “For People’s Health” Medal from Vietnam’s Ministry of Health
2025.3.10
Nagasaki University Secures CEPI Funding to Develop AI-Driven Nanoball Vaccine Technology – Targeting mRNA Vaccine for Severe Fever with Thrombocytopenia Syndrome (SFTS)
2025.3.5
News
Visit from Sukraraj Tropical and Infectious Disease Hospital (STIDH), Kathmandu, Nepal
2024.3.12
Nagasaki University signed an MOU with the International Vaccine Institute (IVI)
2022.9.27
News
Events
Nagasaki University held a launching ceremony for the DEJIMA Infectious Disease Research Alliance and the National Research Center for the Control and Prevention of Infectious Diseases.
View all
2025.12.8
Research Highlights
Highly Pathogenic Virus Therapeutics Development Team:Announcement on「Crimean-Congo hemorrhagic fever virus NSm protein inhibits the type I interferon signaling by binding to STAT2」 2025/11/4
2025.12.1
Research Highlights
Infectious Disease Medical Epidemiology Team:Announcement on「Infectious Disease Medical Epidemiology Team:Announcement on Continuing to be cautious: Japanese contact patterns during the COVID-19 pandemic and their association with public health recommendations」 2025/9/24
2025.12.1
Research Highlights
Infectious Disease Medical Epidemiology Team:Announcement on「Stakeholder meeting report: Chikungunya virus – recent outbreaks, vaccine development and the way forward」 2025/9/19
2025.12.1
Research Highlights
Infectious Disease Medical Epidemiology Team:Announcement on「Disentangling temporal trends of clade Ib monkeypox virus transmission in Burundi」 2025/9/10
2025.12.1
Research Highlights
Infectious Disease Medical Epidemiology Team:Announcement on 「Vaccination strategies to achieve outbreak control for MPXV Clade I with a one-time mass campaign in sub-Saharan Africa: A scenario-based modelling study」 2025/9/5
View all
PAGE TOP